Propantheline
Back to searchMolecule Structure
Scientific Name
Propantheline
Description of the Drug
Propantheline is an antimuscarinic agent used to treat urinary incontinence, hyperhidrosis, as well as cramps and spasms of the stomach, intestines, and bladder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00782
http://www.drugbank.ca/drugs/DB00782
Brand Name(s)
Not Available
Company Owner(s)
Heather Drug Co Inc, Private Formulations Inc, Tablicaps Inc, Sandoz Inc, Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc, Par Pharmaceutical Inc, Watson Laboratories Inc, Gd Searle Llc, Shire Development Inc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL216 |
| Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
| Muscarinic acetylcholine receptor M2 | SINGLE PROTEIN | ANTAGONIST | CHEMBL211 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL80089 | |
| PharmGKB | PA164746224 | |
| Human Metabolome Database | HMDB0014920 | |
| DrugBank | DB00782 | |
| PubChem: Thomson Pharma | 14877274 | |
| PubChem | 4934 | |
| LINCS | LSM-5959 | |
| Nikkaji | J5.464J | |
| BindingDB | 50238663 | |
| EPA CompTox Dashboard | DTXSID6047230 | |
| DrugCentral | 2293 | |
| Guide to Pharmacology | 329 | |
| rxnorm | PROPANTHELINE | PROPANTHELINE BROMIDE |
| KEGG Ligand | C07506 | |
| ChEBI | 8481 | |
| ZINC | ZINC000001530761 |
